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Background: Nonmedical determinants of medical decision making were investigated in an international 
research project in the United States, the United Kingdom, and Germany. The key question in this paper 
is whether and to what extent doctors’ diagnostic and therapeutic decisions in coronary heart disease 
(CHD) are influenced by patient gender.  
Methods: A factorial experiment with a videotaped patient consultation was conducted. Professional 
actors played the role of patients with symptoms of CHD. Several alternative versions were taped 
featuring the same script with patient-actors of different gender, age, race, and socioeconomic status. The 
videotapes were presented to a randomly selected sample of 128 primary care physicians in each country. 
Using an interview with standardized and open-ended questions, physicians were asked how they would 
diagnose and treat such a patient after they had seen the video. 
Results: Results show gender differences in the diagnostic strategies of the doctors. Women were asked 
different questions, CHD was mentioned more often as a possible diagnosis for men than for women, and 
physicians were less certain about their diagnosis with female patients. Gender differences in 
management decisions (therapy and lifestyle advice) are less pronounced and less consistent than in 
diagnostic decisions. Magnitude of gender effect on doctors’ decisions varies between countries with 
smaller influences in the United States.  
Conclusion: Although patients with identical symptoms were presented, primary care doctors’ behavior 
differed by patients’ gender in all 3 countries under study. These gender differences suggest that women 
may be less likely to receive an accurate diagnosis and appropriate treatment than men. 
 
 
Introduction 
The knowledge of gender differences in the morbidity and mortality of coronary heart disease (CHD) is 
well established (Central Health Monitoring Unit, 1994; Derby, Lapane, Feldman, & Carleton, 2000; 
National Center for Health Statistics, 2005; Statistisches Bundesamt, 2006; Tunstall-Pedoe, Morrison, 
Woodward, Fitzpatrick, & Watt, 1996). These differences are often described as results of biological 
processes and unhealthy lifestyle behaviors that influence coronary risk. Estrogens are discussed to have a 
protective effect for women (Mendelsohn, 2002; Rossouw et al., 2007). In contrast, men’s different health 
lifestyles could cause a coronary illness. Gender-specific behaviors (e.g., smoking, a high level of alcohol 
consumption) increase the probability for CHD (Yusuf et al., 2004). These gender differences in the 
prevalence of CHD and risk behavior are well known by most general practitioners, yet doctors could 
hold stereotypical views on what kind of patients are at risk for CHD and those who are not. These views 
could affect the probability of being correctly diagnosed and treated for certain patient groups (Bond et al., 
2003; Van Ryn & Fu, 2003). For example, female patients who are at a lower risk of CHD (overall) are at 
risk of not being diagnosed accurately. Thus, mediated by these stereotypes, nonmedical factors could 
affect the doctors’ decision making process and subsequently the therapeutic outcome of a patient with 
symptoms of CHD (Anand, Xie, & Metha, 2005; Arber et al., 2004, 2006; Bönte et al., 2007; Frich, 
Malterud, & Fugelli, 2006; McKinlay, Lin, Freund, & Moskowitz, 2002; Mikhail, 2006). In research on 
health disparities, provider behaviour itself is often unaddressed, although it is important to understand 
the development of epidemiologic gender differences. Furthermore, information about gendered care 
pathways in CHD are relatively well documented, but primarily focused on differences within secondary 
care. Raine (2000) provides evidence for the existence of gender bias in the use of specialist services by 
critically appraising the literature. His review indicates that female patients are less likely than male 
 2 
patients to undergo CHD-related diagnostic investigations and surgical treatment. Recent studies from the 
United States show that gender disparities in the quality of health services provided to patients with acute 
myocardial infarction are a consistent phenomenon across different population groups (Correa-de-Araujo 
et al., 2006) and among patients with the same health insurance (Chou et al., 2007). Another limitation of 
many studies on medical decision making is that they do not control for other potential patient factors 
(like age, ethnicity, or social status) or physicians’ attributes (like gender and age) that might influence 
the doctors’ decisions (Feldman, Freund, Burns, Moskowitz, & Kasten, 1997). In addition, results are 
often limited to 1 region or country and the role of the health care system in which patients are diagnosed 
and treated is often not taken into account. Comparative research in this field is important to determine 
the contribution of the health care system to health disparities (Blendon, Schoen, DesRoches, Osborn, & 
Zapert, 2003; Blendon et al., 2004; Herlitz et al., 2003; Schoen et al., 2004). In this regard, McKinlay et 
al. (2006) described how doctors in the United States and the United Kingdom manage the same patient. 
Without analyzing the effect of gender specifically, their results show a high level of consistency in 
medical decision making for CHD in the 2 countries. However, British doctors were less certain with the 
diagnosis and asked more additional questions than their American colleagues. Arber et al. (2004, 2006) 
analyzed the influence of patient gender on the decision making process for these 2 countries together. 
Findings indicate that doctors’ diagnostic and management strategies relating to CHD vary by patient 
gender, to the disadvantage of women. In this paper, gender effects on the diagnosis and treatment of 
CHD are presented separately for 3 countries with different health insurance systems (a largely private 
insurance-based health care system in the United States; a National Health Service that is a government-
supported, taxation-based system in the United Kingdom; and a system characterized by decentralized 
care administered by social security agencies in Germany). The aim is to examine whether gender 
disparities in the diagnosis and treatment of CHD vary in different health care systems or if they are a 
cross-national invariant phenomenon. 
 
Methods 
Design and Contents of the Video Vignettes 
In this study, a factorial experimental design with portrayed video vignettes was used (Feldman et al., 
1997). To develop the script for the video vignettes, clinical consultants role played actual office visits. 
This step was essential to ensure clinical accuracy. Professional actors were used to portray medical 
encounters on videotape in which the “patient” presented with 7 signs and symptoms that are typical for 
CHD including chest pain; pain worsened with exertion, stress, and eating; relief after resting; discomfort 
for >3 months; pain through the back between the shoulder blades; and elevated blood pressure. In 
addition, a key nonverbal cue was incorporated, demonstrated by the “Levine fist,” where the patient 
clenched his fist to the sternum (Marcus et al., 2007). This single script was used for all videotapes 
presented to the physicians. Thus, all videotapes had exactly the same text. The patient in the videotapes 
was portrayed as consulting this doctor for the first time with these symptoms. The portrayed physicians 
and patients in the United States had American accents, and the very same vignette physicians and 
patients in the United Kingdom had British accents. In Germany, the physician and patient voices were 
dubbed by a professional speaker. Professional actors were trained under experienced physician 
supervision to realistically portray a patient presenting the symptoms of disease to a primary care provider. 
Care was taken to construct a culturally neutral set, neutral clothes, and a cultureneutral facial expression. 
The video was presented to primary care doctors in their practice. Actors on the tapes differed according 
to gender (male vs. female), age (55 vs. 75 years), race (black vs. white), and social status (low vs. high) 
to mirror respective patient characteristics. In the present analyses, we focus on differences between 
female and male patients. 
 
Instruments 
One CHD video was presented to each physician. Thereafter, physicians were asked various questions 
regarding diagnosis and treatment in a personal interview with standardized and open-ended questions. In 
terms of diagnostic decision making, the first question was whether the physician would ask the patient 
any additional questions and if so, what kind of question(s). Second, doctors were asked what they 
thought was going on with the patient and how certain they were with their diagnostic decision. Moreover, 
physicians were asked to name diagnostic tests they would order for this patient. In terms of the 
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management of the patient, we wanted to know if they would prescribe or recommend any medication, if 
they would refer the patient to another health care professional, and when they would like to see the 
patient again. Finally, physicians were asked if they would recommend any lifestyle advice or behavior 
change. 
 
Physician Sample 
Physicians were randomly selected from lists provided by local health care organizations. Selection was 
made within 4 strata, defined by combinations of the physicians’ gender and length of clinical experience 
(<5 years or >15 years). To be eligible for participation, physicians had to be internists or family 
practitioners in the United States and in Germany or general practitioners in the United Kingdom. In 
addition, they had to be working at least half time and had to be trained at an accredited medical school in 
the country in which they were practicing. A letter of invitation was sent to selected doctors who met 
these criteria. Thereafter, screening telephone calls were conducted to identify eligible physicians and an 
appointment was scheduled for a 1-hour, in-person, structured interview conducted in the physician’s 
practice. Each physician subject was provided a modest stipend to partially offset lost revenue and to 
acknowledge their participation. The response rate was 64.9% in the United States, 59.6% in the United 
Kingdom, and 65.0% in Germany. Altogether, 384 interviews were conducted in the United States 
(Massachusetts) in the United Kingdom (the West Midlands, SW London, and Surrey) and in Germany 
(North Rhine-Westphalia). The final sample included 64 female and 64 male primary care doctors in each 
country, half of them with <5 years of clinical experience, the other half with >15 years. For a sample size 
of 128 per country the design has 80% power to detect differences of 25%. For example, if 25% of 
physicians would refer a female patient to a cardiologist/specialist facility and 50% of physicians would 
refer a male patient to a cardiologist/ specialist facility (a difference of 25%), then we would expect to 
find a significant difference (at alpha = 0.05) 80% of the time. For a sample size of 384 (all 3 countries), 
the design has 80% power to detect of difference of 14.5%.  
 
Analyses 
Analysis of variance (ANOVA) was used to assess the effect of patients’ gender on doctors’ diagnostic 
and therapeutic decisions. Because a balanced factorial design was used, the effects due to patient gender 
are unconfounded (orthogonal to) with the other design effects (patient age, socioeconomic status, and 
race, as well as physician gender and physician level of experience). Precise p-values are reported in the 
tables. p < .05 was considered significant. For the data analysis of the open-ended questions, coding 
frames were developed and answers were summarized into categories (e.g., antihyperlipidemics, ß-
blockers, calcium channel blockers, salicylates, and vasodilating agents were coded as CHD-appropriate 
prescriptions). These coding frames were finalized after achieving >90% intercoder reliability between 
medical advisers in the 3 countries. 
 
Results 
Questioning 
Table 1 shows that women presenting with CHD symptoms would generally receive less attention than 
men. They would be asked fewer questions in the United Kingdom and in the United States, although this 
gender difference failed to reach statistical significance (p< .05). Moreover, the topics of the questions 
differ between women and men. This especially holds for the United Kingdom, where significantly more 
men would have been asked about their medical history, about smoking, alcohol consumption, and their 
psychological state, whereas significantly more women would have been asked about their general health 
status. In Germany, women are significantly less likely to be asked about smoking and alcohol, and in the 
United States gender differences are significant only for questions about smoking. Looking at the 3 
countries together, the gender differences in all areas of physician’s questioning are significant (p< .05). 
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Table 1. Gender comparison of the total number and kind of questions physicians would ask the patient by country 
 
 All 3 Countries Germany UK US 
 Male Female p Male Female p Male Female p Male Female p 
Number of 
questions 
(mean) 
6.2* 5.3* .012* 3.2 3.0 .676 6.1 5.0 .054 9.4 7.9 .091 
Questions 
about (%) 
            
Medical 
history 
66* 57* .033* 40 38 .685 73* 52* .010* 84 81 .639 
Smoking 55* 29* <.001* 28* 12* .005* 67* 30* <.001* 69* 45* .004* 
Alcohol 32* 17* <.001* 14* 2* .014* 41* 22* .009* 41 28 .149 
Psychological 
state 
36* 23* .006* 23 17 .397 42* 23* .032* 42 28 .100 
General health 
status 
54* 63* .030* 23 38 .054 55* 69* .010* 83 83 1.000 
*p < .05. 
 
 
CHD Diagnosis 
Table 2 shows that CHD was mentioned more often as a possible diagnosis for men than for women with 
a significant gender effect in Germany. In addition, on a scale from 0 (total uncertainty) to 100 (total 
certainty), doctors were significantly more certain of their CHD diagnosis with male than with female 
patients in the United Kingdom and in the United States. If they mentioned CHD as a possible diagnosis, 
significantly more doctors would order a test for CHD if the patient was a man in Germany. Again, 
looking at the 3 countries together, all gender differences related to the CHD diagnosis are significant at 
the 5% probability level. 
 
 
Table 2. Gender comparison of correct CHD diagnosis, certainty of diagnosis, and test ordering for CHD by country 
 
 All 3 Countries Germany UK US 
 Male Female p Male Female p Male Female p Male Female p 
CHD diagnosis 
(%) 
91* 81* .004* 81* 67* .033* 94 83 .076 97 94 .417 
Certainty of 
CHD diagnosis 
(0–100%) 
52* 44* .006* 41 37 .487 52* 40* .028* 62* 54* .048* 
Test for CHD 
(%) 
76* 63* .002* 48* 30* .027* 88 73 .065 92 86 .252 
No. of tests for 
CHD 
(mean) 
2.8* 2.3* .015* 1.1 0.7 .095 4.0 3.1 .073 3.4 3.0 .386 
Abbreviation: CHD, coronary heart disease. 
*p < .05. 
 
 
Therapy 
As shown in Table 3, gender differences were also evident in doctors’ management decisions. In the 
United Kingdom, men would be significantly more likely than women to receive an appropriate 
prescription for possible CHD after the first contact. Moreover, men would be more likely to be referred 
to a cardiologist or a specialist facility in Germany and in the United Kingdom. Gender difference in days 
to the next appointment was not significant in any country. Effects of patient’s gender on therapeutic 
decisions were nonsignificant in the United States. 
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Table 3. Gender differences in the therapy for CHD by country 
 
 All 3 Countries Germany UK US 
 Male Female p Male Female p Male Female p Male Female p 
CHD 
appropriate 
prescription 
(%) 
50* 39* .015* 22 12 .139 58* 39* .044* 70 64 .458 
Referral to a 
cardiologist or 
specialist 
facility (%) 
25* 15* .011* 27* 11* .037* 39* 23* .037* 9 11 .764 
Referral to 
other medical 
professional 
(%) 
33* 25* .044* 61* 42* .027* 31 30 .853 8 3 .185 
Days to next 
appointment 
(mean) 
9.6 10.5 .167 4.7 6.8 .080 12.3 14.0 .218 11.8 10.7 .510 
Abbreviation: CHD, coronary heart disease. 
*p  <.05. 
 
 
Advice Giving 
Doctors were asked if they would give the patient any advice to change their lifestyle behavior. Table 4 
shows that on average 2.5 pieces of advice would be given to the patient across all countries combined. 
The amount of advice did not vary by gender overall or within a given country. Advice about smoking 
would be given to more male than female patients, although this failed to reach statistical significance 
(p< .05) in each of the 3 countries. There was only 1 significant difference in advice giving by patients’ 
gender: Physicians would only recommend reducing weight if the patient was a man in Germany. Figure 
1 summarizes the results on gender differences in clinical decision making overall and by country. 
Although the significance level of many factors varies by county, it should be noted that there were no 
significant country by gender interactions (p > .05 for all tests). 
 
 
Table 4. Gender differences in the lifestyle advice for patients with CHD by country 
 
 All 3 Countries Germany UK US 
 Male Female p Male Female p Male Female p Male Female p 
No. pieces of 
advise 
(mean) 
2.5 2.5 .786 1.9 1.8 .780 2.8 3.1 .270 2.9 2.7 .641 
Advice about 
(%) 
            
Diet 52 54 .537 50 52 .858 47 59 .149 58 53 .603 
Smoking 38* 26* .004* 12 5 .137 62 47 .073 39 25 .088 
Alcohol 21 21 1.000 8 12 .321 36 36 1.000 20 15 .441 
Relaxation 9 7 .578 10 6 .369 11 11 1.000 5 5 1.000 
Weight 5 4 .809 6* 0* .049* 6 9 .529 2 3 .566 
Abbreviation: CHD, coronary heart disease. 
*p < .05. 
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Figure 1. Gender differences in clinical decision making overall and by country 
Discussion 
This paper focuses on the role of patient gender for clinical decision making in CHD in the United States, 
United Kingdom, and Germany. Because vignettes are a valid and comprehensive method for measuring 
the quality of care provided by physicians (Peabody, Luck, Glassman, Dresselhaus, & Lee, 2000), a 
factorial experiment with video vignettes was conducted in the 3 countries. Results show gender 
differences in the diagnostic strategies of the doctors (information seeking, possible diagnosis). Although 
there are crossnational differences in magnitude, indicating strongest effects of gender on doctors’ 
questioning in the United Kingdom, a consistent general trend can be observed in all countries: Female 
patients would receive less questioning and were less likely to receive an accurate diagnosis by primary 
care doctors. Moreover, results indicate that differences in therapy decisions (prescription, referrals, and 
lifestyle advice) according to patients’ gender are less pronounced and less consistent than in diagnostic 
decisions. Gender differences in physician decision making among patients presenting with symptoms of 
CHD were described earlier (Arber et al., 2004, 2006). Based on this knowledge, we have chosen a 
comparative perspective for our analyses. Although all 3 countries show a similar trend, the magnitude of 
the gender effect on doctors’ decisions varies between countries with smaller influences of the patient’s 
gender in the United States. Stereotypical beliefs about what kinds of patients are at risk for CHD might 
influence the decision making process (Arber et al., 2004, 2006; Adams et al., 2006; Bönte et al., 2007). 
If those stereotypes are aligned with the knowledge of sociodemographic differences in the risk structure 
of CHD, this strategy could lead to a more precise targeting of diagnostic and therapeutic arrangements. 
But working with standardized videotaped patients, where all male and female actors express exactly the 
same symptoms, treatment differences are not indicated. In fact, lower detection rates of CHD among 
female patients could have serious consequences for their health. It seems that the epidemiologic 
knowledge of higher CHD rates among men could lead the doctors to concentrate their attention on a 
coronary diagnosis among male patients and to underdiagnose CHD among women. This assumption is 
supported by the fact that gender differences in the diagnosis of CHD in the present study are more 
pronounced among midlife patients (55 years) than among older patients (75 years; results not shown). 
This “gendered ageism” (Arber et al., 2006) can be seen in the context of known prevalence and risk 
profiles. Well-known variations in illness rates by gender are therefore not only a consequence of 
differences in the biological or behavioral risk structure, but might also be socially constructed (Horton, 
2007). In a qualitative work, Adams et al. (2007) explored sources of gender bias in the decision making 
process of primary care doctors in the United Kingdom and United States. During the interviews that 
were part of the present study, doctors were asked to explain and justify diagnostic and therapeutic 
decisions for a CHD patient. Findings revealed an interaction of physicians’ and patients’ gender. Male 
doctors appeared less affected by patient gender, but both male and especially female doctors took more 
account of male patients’ age and considered more age-related disease possibilities for men than women. 
It is a future task to analyze the qualitative data collected in the present study to provide more information 
on how patient gender affects doctors’ cognitive processes during consultations. Although the rigorous 
experimental design permits excellent internal validity, external validity remains a threat. Several 
precautionary steps were taken to minimize this threat. The physicians were specifically instructed to 
view the patient on the videotape as one of their own cases. In addition, the doctors viewed the tapes in 
the context of their practice day and not at a professional meeting, a course update, or in their home. Thus, 
it was likely they encountered real patients before and after they viewed the patient in the videotape. To 
enhance the clinical authenticity of the videotaped patient, the script of the vignette was based on role 
plays conducted with skilled physicians. During the production of the videos, experienced clinicians were 
present, and only professional and experienced actors were used. At the beginning of each interview, 
doctors were asked how typical the videotaped patient was compared with patients they see in their 
practice. In the United States, 90.6% of doctors, and 91.4% in the United Kingdom, and 81.3% in 
Germany considered them as very or reasonably typical. Using Tukey’s multiple comparisons to test for 
differences between the 3 countries, we found that rating in Germany is significantly (p = .0102) lower 
than in the United Kingdom or in the United States. The lower rate in Germany might be a result of the 
dubbing that makes the scenario more unrealistic than in the 2 other countries. Additionally, interviewers 
were carefully trained and certified and frequent transatlantic telephone calls were conducted to ensure 
standardized interviewing and to minimize interviewer variability (Johannes, Crawford, & McKinlay, 
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1997). Quality control interviews and site visits were conducted and selected tape recorded interviews 
were reviewed by supervisors on a regular basis to minimize variation within the 3 countries. However, 
although substantial effort was devoted to produce the video vignettes as realistic as possible, videotapes 
are not the same as real patients. Diagnostic and therapeutic decisions result through the interaction of 
doctor and patient. This issue could not be addressed in a videotape-based experiment. In addition, 
doctors might have viewed the interview as a test. This could potentially bias the answers in the direction 
of social acceptability. To avoid this, the doctors were told that the interview is not a test and that there 
are no right or wrong answers. These (potential) limitations are counterbalanced by several strengths. 
Through the factorial experimental approach, relevant influences on the decision-making process are 
controlled by the study design. This allows the estimation of the independent and unconfounded effects of 
the respective factors (e.g., gender of the patient) (Cochran & Cox, 1957; Feldman et al., 1997; Kirk, 
1982). Moreover, the design offers the possibility to integrate nonverbal signs like the “Levine fist.” 
Finally, physicians were randomly selected to enhance generalizability. In conclusion, gender differences 
in the diagnosis and management of CHD seem to be a generalized, although not invariant phenomenon. 
Future studies should give more attention to international variations in health care disparities to determine 
the contribution of the health care system to such disparities (McKinlay et al., 2006). To improve our 
understanding of the women’s role as well as her cultural and socioeconomic status, other countries 
should be included in respective studies. Findings should be part of the physicians’ further training in 
order to reduce gender disparities in the daily medical practice. 
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